Exploration and Practice of Introducing the Pharmaceutical Care Network Europe Classification System to Psychiatric Drugs

This research aims to summarize and discuss issues related to psychiatric drugs by using the classification system of the Pharmaceutical Care Network Europe (PCNE) and to provide a reference for the development and direction of clinical pharmacists’ work in the future. Psychiatric patients who were...

Full description

Saved in:
Bibliographic Details
Published in:Journal of pharmacy practice 2025-02, Vol.38 (1), p.74-80
Main Authors: Shi, Menglan, Ma, Yan, Li, Hong, Li, Fangjie, Shen, Shujuan
Format: Article
Language:English
Subjects:
Adult
Aged
Drug-Related Side Effects and Adverse Reactions - prevention & control
Europe
Female
Humans
Male
Mental Disorders - classification
Mental Disorders - drug therapy
Middle Aged
Pharmaceutical Services - organization & administration
Pharmacists
Pharmacy Service, Hospital - organization & administration
Psychotropic Drugs - classification
Psychotropic Drugs - therapeutic use
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This research aims to summarize and discuss issues related to psychiatric drugs by using the classification system of the Pharmaceutical Care Network Europe (PCNE) and to provide a reference for the development and direction of clinical pharmacists’ work in the future. Psychiatric patients who were hospitalized in our hospital from Janurary 2023 to December 2023 were enrolled. Drug-related problems (DRPs) were evaluated using the PCNE classification system (version 9.0). The types, causes, intervention plans, acceptance of intervention plans, and statuses of DRPs were analyzed. A total of 362 patients were included, covering 405 DRP cases, with an average DRP of 1.12 for each patient. All 405 DRP cases underwent interventions, with a success rate of 83.46%. The main categories of related drugs were psychotropic drugs (70.37%), anti-infective drugs (8.89%), and cardiovascular system drugs (5.19%). The main DRPs were possible adverse drug events (21.24%), poor treatment effects (69.14%), and unnecessary medication treatment (9.63%). The main causes of DRPs were inappropriate drug selection (18.52%), inappropriate combinations of drugs (16.05%), and excessive drug dosage (13.58%). The PCNE classification system helps clinical pharmacists improve their ability to identify and solve DRPs faced by psychiatric departments, improve pharmaceutical care efficiency, and ensure rational drug use.
ISSN:0897-1900
1531-1937
1531-1937
DOI:10.1177/08971900241273200